$19.010
+0.513 (+2.70%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
RLAY 相似圖表分析預測
Alphio's RLAY stock price prediction model matches the current Relay Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.94 (-0.53%). The 1-week path is $20.87 (+9.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Relay Therapeutics Inc 股票嗎？
Relay Therapeutics Inc is a good buy right now due to its current price of $18.77, which is significantly below analyst price targets of $29 and $31, indicating potential upside. Additionally, the company has a robust gross margin of 100% and a strong year-to-date change of +129.46%, reflecting its growth potential despite recent insider selling. The main risk is the negative net income, which stands at -83,707,000 USD for Q2 2026, indicating ongoing financial challenges.
RLAY 股價於 Thursday 收在 $19.01，此前上漲 +2.70%
Relay Therapeutics Inc (RLAY) last closed at $19.04, gaining +0.16%. These facts feed the 1-day and 1-week RLAY price prediction above.
預測驅動因素
Relay Therapeutics Inc（RLAY）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 RLAY 最接近的股票，依相似度排序。
RLAY 季節性分析
Historically the probability of a positive September return for RLAY is 28.89%. December offers the highest probability of a positive month at 51.16%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。